LILIAN MUGARTEGUI: Open Payments
NPI 1891063004 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 3 payments from 3 companies in 2025. Trend: 2023 $125 · 2024 $112 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 1 | $124 |
| Fresenius Kabi USA, LLC | 1 | $123 |
| La Jolla Pharmaceutical Company | 1 | $122 |
Products named: UPTRAVI, Smoflipid, ZEVTERA.
Industry payments across TX — which companies pay providers there.
